GSK's split year performance
Without the complication of legal charges,
's (GSK) reported profits returned to something resembling normality, which perhaps gave traders an excuse to lock-in profits on the sizeable share price gains seen in recent months. Moreover, shareholders can expect a further £1bn-£2bn of share buy-backs this year - as well as a 5p special dividend, from selling peripheral over-the-counter products.
story-url-GSK finals 12 070212.xml
By Julian Hofmann,
07 February 2012